MyoKardia Provides Clinical Trial Update in the Context of the COVID-19 Pandemic

Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb

Fulcrum Therapeutics Announces Complete Data from Phase 1 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)

Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator

CytomX Therapeutics Announces Appointment of Carlos Campoy as Chief Financial Officer